Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898937 · ClinicalTrials.gov registry record
Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast
A clinical trial, sponsored by Georgetown University.
- Terminated
- Registry status
- 55
- Enrollment target
NCT00898937 is a clinical trial that was terminated before completion, run by Georgetown University. The registered enrollment target is 55 participants.
The verdict
NCT00898937 was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- 55 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue. PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.
Interventions
- GENETIC microarray analysis
- PROCEDURE breast biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 1999-09 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898937
The ClinicalTrials.gov registry entry for NCT00898937 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00898937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898937 about?
NCT00898937 is a clinical study titled "Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast". RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue. PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.
What is the current status of trial NCT00898937?
This trial is currently terminated. The enrollment target is 55 participants. The study started on 1999-09. Estimated completion is 2017-07.
What interventions are being tested in trial NCT00898937?
The interventions under investigation include: microarray analysis (GENETIC), breast biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00898937?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.